共 241 条
[1]
Llover JM(2008)SHARP Investigators Study Group. Sorafenib in advanced hepatocellular carcinoma N Engl J Med 359 378-390
[2]
Ricci S(2009)Phase II trial of sorafenib in patients with metastatic breast cancer previously exposed to anthracyclines or taxanes: North Central Cancer Treatment Group and Mayo Clinic Trial N0336 J Clin Oncol 27 11-15
[3]
Mazzaferro V(2006)Phase II study of sorafenib in patients with advanced hepatocellular carcinoma J Clin Oncol 24 4293-4300
[4]
Hilgard P(2009)Sorafenib in unresectable hepatocellular carcinoma from mild to advanced stage liver cirrhosis Oncologist 14 70-76
[5]
Gane E(2010)Management of hepatocellular carcinoma in Japan: consensus-based clinical practice guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version Dig Dis 29 339-364
[6]
Blanc JF(1995)The efficacy of continuous local arterial infusion of 5-fluorouracil and cisplatin through an implanted reservoir for severe advanced hepatocellular carcinoma Oncology 52 295-299
[7]
de Oliveira AC(2003)Low-dose chemotherapy of cisplatin and 5-fluorouracil or doxorubicin via implanted fusion port for unresectable hepatocellular carcinoma Anticancer Res 23 1719-1722
[8]
Santoro A(1999)Hepatic arterial infusion chemotherapy with continuous low dose administration of cisplatin and 5-fluorouracil for multiple recurrence of hepatocellular carcinoma after surgical treatment Oncol Rep 6 587-591
[9]
Raoul JL(2008)Therapeutic strategy of advanced hepatocellular carcinoma by using combined intra-arterial chemotherapy Recent Pat Anticancer Drug Discov 3 220-226
[10]
Forner A(2007)Twenty-four hour intra-arterial infusion of 5-fluorouracil, cisplatin, and leucovorin is more effective than 6-hour infusion for advanced hepatocellular carcinoma World J Gastroenterol 13 280-284